Main Menu

The Institute of Cancer Research, London, is one of the world’s most influential cancer research organisations. Today, read about our childhood leukaemia appeal, opportunities for early-career researchers, or sign up to one of our email newsletters.

Back to top
  • Targeting inflammation could help treat drug-resistant bowel cancer

    Targeting inflammation could help treat drug-resistant bowel cancer

    Some bowel cancers that are resistant to treatment could be re-sensitised using drugs that reduce inflammation, according to new research.

    Read more
  • Help us defeat childhood leukaemia

    Help us defeat childhood leukaemia

    Our latest research shows that within the next decade, we can make acute lymphoblastic leukaemia preventable. Your support will help us make this disease a thing of the past.

    Donate
  • Call for hospitals to use high-tech scans to diagnose prostate cancers when they can still be cured

    Call for hospitals to use high-tech scans to diagnose prostate cancers when they can still be cured

    Modern, sophisticated scans should be used in hospitals to pick out men whose prostate cancers have only spread to a limited number of sites, so they can be offered the chance of cure, a new assessment concludes.

    Read more
  • Patients with HPV-positive throat cancer should keep taking chemotherapy

    Patients with HPV-positive throat cancer should keep taking chemotherapy

    Patients with human papillomavirus (HPV)-positive throat cancer should carry on receiving chemotherapy rather than switching to a targeted cancer drug, new clinical trial results have shown.

    Read more
  • Find out more about our ICR newsletters

    Find out more about our ICR newsletters

    The Institute of Cancer Research currently produces several email newsletters, including 'Search' which brings you our latest news, recent research achievements and interviews with our world-leading scientists and clinicians.

    Find out more
1/5

Childhood leukaemia appeal

Our latest research shows that within the next decade, we can make acute lymphoblastic leukaemia preventable. Your support will help us make this disease a thing of the past.

Donate

How we work with industry

We work in close partnership with industry to take results into the clinic as soon as possible, and make sure our research delivers for cancer patients.

Find out more

Our scientific discoveries

For more than 100 years, the ICR has played an important role in shaping understanding of cancer and how it can be treated.

Find out more

Share your story

We always want to hear from people who have a cancer story to share. Get in touch and help raise awareness of our research.

Find out more

Our research excellence

The ICR is the top-ranked academic research centre in the UK after coming first overall in the 2014 Research Excellence Framework.

Find out more

The Drug Discoverer

Our Chief Executive and President, Professor Paul Workman, shares his experiences on his blog, The Drug Discoverer.

Find out more
We use cookies to ensure that we give you the best experience on our website. By continuing to use this website, you are agreeing to our use of cookies on your device as described in our cookie policy. You can change your cookie settings at any time but parts of our site will not function correctly without them.